183 related articles for article (PubMed ID: 32569747)
1. Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis.
Stavniichuk A; Hye Khan MA; Yeboah MM; Chesnik MA; Jankiewicz WK; Hartmann M; Blöcher R; Kircher T; Savchuk O; Proschak E; Imig JD
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106472. PubMed ID: 32569747
[TBL] [Abstract][Full Text] [Related]
2. A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
Hye Khan MA; Kolb L; Skibba M; Hartmann M; Blöcher R; Proschak E; Imig JD
Diabetologia; 2018 Oct; 61(10):2235-2246. PubMed ID: 30032428
[TBL] [Abstract][Full Text] [Related]
3. Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis.
Khan MAH; Nolan B; Stavniichuk A; Merk D; Imig JD
Front Immunol; 2023; 14():1269261. PubMed ID: 38235144
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
Kim J; Imig JD; Yang J; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F971-80. PubMed ID: 25164080
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
6. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
Makled MN; El-Kashef DH
Life Sci; 2020 Jul; 253():117729. PubMed ID: 32348836
[TBL] [Abstract][Full Text] [Related]
7. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.
Choi HS; Song JH; Kim IJ; Joo SY; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
Sci Rep; 2018 Aug; 8(1):11546. PubMed ID: 30068917
[TBL] [Abstract][Full Text] [Related]
9. Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ.
Zhang ZH; He JQ; Zhao YY; Chen HC; Tan NH
Acta Pharmacol Sin; 2020 Mar; 41(3):373-382. PubMed ID: 31705123
[TBL] [Abstract][Full Text] [Related]
10. THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODEL.
Stavniichuk A; Savchuk O; Khan AH; Jankiewicz WK; Imig JD; Merk D
Visnyk Kyivskoho Natsionalnoho Universytetu Imeni Tarasa Shevchenka Biolohiia; 2020; 80(1):10-15. PubMed ID: 33437972
[TBL] [Abstract][Full Text] [Related]
11. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice.
Higashi K; Oda T; Kushiyama T; Hyodo T; Yamada M; Suzuki S; Sakurai Y; Miura S; Kumagai H
Nephrology (Carlton); 2010 Apr; 15(3):327-35. PubMed ID: 20470302
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates renal fibrosis through the induction of autophagy.
Kawaoka K; Doi S; Nakashima A; Yamada K; Ueno T; Doi T; Masaki T
Clin Exp Nephrol; 2017 Oct; 21(5):771-780. PubMed ID: 27928635
[TBL] [Abstract][Full Text] [Related]
14. UT-A1/A3 knockout mice show reduced fibrosis following unilateral ureteral obstruction.
Rianto F; Kuma A; Ellis CL; Hassounah F; Rodriguez EL; Wang XH; Sands JM; Klein JD
Am J Physiol Renal Physiol; 2020 May; 318(5):F1160-F1166. PubMed ID: 32174141
[TBL] [Abstract][Full Text] [Related]
15. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.
Kawai T; Masaki T; Doi S; Arakawa T; Yokoyama Y; Doi T; Kohno N; Yorioka N
Lab Invest; 2009 Jan; 89(1):47-58. PubMed ID: 19002105
[TBL] [Abstract][Full Text] [Related]
16. Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.
Cao J; Wang W; Li Y; Xia J; Peng Y; Zhang Y; Xia A
Int Urol Nephrol; 2016 Apr; 48(4):619-29. PubMed ID: 26865179
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
[TBL] [Abstract][Full Text] [Related]
18. Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease.
Zhang A; Wang H; Wang B; Yuan Y; Klein JD; Wang XH
FASEB J; 2019 Dec; 33(12):13590-13601. PubMed ID: 31593640
[TBL] [Abstract][Full Text] [Related]
19. Methionine sulfoxide reductase A deficiency exacerbates progression of kidney fibrosis induced by unilateral ureteral obstruction.
Kim JI; Noh MR; Kim KY; Jang HS; Kim HY; Park KM
Free Radic Biol Med; 2015 Dec; 89():201-8. PubMed ID: 26210777
[TBL] [Abstract][Full Text] [Related]
20. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
